Skip to content

CMTA Press Room

Official News From Charcot-Marie-Tooth Association

CMTA’s Press Room Is Where We Share News That Shapes Not Only the Future of CMT Research but Real Impact Today. From Funding Announcements to Trial Updates, This Is Where Progress Moves From Idea to Action.


  • CMTA Invests $110,500 in Novel ASO Medicine for CMT2A

    CMTA Invests $110K in Novel ASO for CMT2A

    The Charcot-Marie-Tooth Association announced a $110,500 investment partnering with La Jolla Labs to develop an…

  • CMTA Invests $165,000 in CMT1A and CMT1E Treatments

    When Should CMT1A and CMT1E Treatment Begin?

    CMTA invests $165,000 in University of Iowa research led by Michael Shy, MD, and Robert…

  • CMTA Adds $225,720 for CMT1B and CMT1E Drug Repurposing

    CMTA Expands CMT1B and CMT1E Research

    CMTA is investing $225,720 to expand drug repurposing research into CMT1B and CMT1E, building on…

  • CMTA Appoints Aimee Yrlas Simpson as Chief Revenue Officer

    Aimee Yrlas Simpson Named CMTA Chief Revenue Officer

    CMTA appoints Aimee Yrlas Simpson as Chief Revenue Officer, bringing more than 25 years of…

  • Vincent Timmerman Joins CMTA-STAR Scientific Advisory Board

    CMT Pioneer Joins CMTA-STAR Advisory Board

    Vincent Timmerman, PhD, the Belgian geneticist whose lab identified the first known genetic cause of…

  • CMTA Receives $154,000 ACA Grant for Camp Footprint

    Camp Footprint Receives $154K National Grant

    CMTA has received a $154,000 American Camp Association Character at Camp Implementation Grant to launch…

  • CMTA Invests $141,000 to Study Hearing and Balance in CMT

    CMTA Invests $141K in Hearing and Balance Study

    CMTA is supporting a two-year research project examining hearing and balance signaling to strengthen outcome…

  • CMTA Adds David Stark and Catherine Illingworth to Board

    CMTA Appoints David Stark and Catherine Illingworth to Board of Directors

    CMTA welcomes David Stark, MD, and Catherine Illingworth to its Board of Directors, strengthening clinical…

  • CMTA Tackles CMT Delivery Challenge With Four Investments

    Solving the CMT Treatment Delivery Challenge

    CMTA announced $523,000 in funding for four research projects focused on solving one of the…

  • CMTA Appoints Wendy Arnone as Board Chair

    CMTA Appoints Wendy Arnone as Board Chair

    CMTA has appointed Wendy Arnone as board chair, succeeding Gilles Bouchard, who has led the…

  • CMTA Invests $100,000 in EverTree Bio for CMT1A Research

    CMTA Invests $100,000 in EverTree Bio

    CMTA announces a $100,000 investment in EverTree Bio to support continued development of an early-stage…

  • CMTA Appoints Catie Coman as Chief Marketing Officer

    CMTA Appoints Catie Coman Chief Marketing Officer

    Coman brings more than 15 years of experience in patient advocacy and has worked with…

Want the latest CMT research, news, and community updates delivered to your inbox?

Sign up for CMTA’s eNews and stay connected with the latest in CMT and CMTA news and events.

Your Pathway Doesn’t End Here. Your Journey Continues.

Where to Next?